Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education; Joslin's Boards of Trustees and Overseers work in tandem with the executive team.
Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge – a hallmark of this one-of-a-kind Center.
Publicly representing the institution, Joslin's Board of Trustees comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.
Board of Trustees
Peter S. Amenta, M.D., Ph.D. - University of Medicine and Dentistry of NJ, Robert Wood Johnson Medical School, New Brunswick, NJ
John J. Cook, Jr. - Managing Director, Seaward Management Corp., Boston, MA
Nathaniel S. Gardiner - Edwards Wildman Palmer LLP, Boston, MA
Morella M. Grossmann - Caracas, Venezuela
Ralph M. James, Chairperson of the Board - Executive Director, External Relations, Harvard Business School, Boston, MA
Ann M. Lagasse - Newburyport, MA
James L. Peterson - Corseaux, Switzerland
Geoffrey S. Rehnert - Founder and Co-CEO, Audax Group, Boston, MA
Mark E. Russell - Vice President, Raytheon Company, Waltham, MA
Richard A. Smith - Chestnut Hill, MA
John L. Brooks III - President and CEO, Joslin Diabetes Center, Boston, MA
Martin J. Abrahamson, M.D. - Senior Vice President and Chief Medical Officer, Joslin Diabetes Center, Boston, MA
George L. King, M.D. - Senior Vice President and Chief Scientific Officer, Joslin Diabetes Center, Boston, MA
W. Ray Allen - Coral Gables, FL
Charles H. Hood - Brookline, MA
Patrick H. O’Neill - New Canaan, CT
Kenneth E. Quickel, M.D. - Oak Park Heights, MN
Page last updated: January 16, 2013